BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7944500)

  • 1. [A case of metastatic breast cancer successfully treated with weekly low-dose epirubicin (EPI), cyclophosphamide (CPA), 5-fluorouracil (5-FU) and medroxyprogesterone (MPA)].
    Satoh Y; Une Y; Fujisawa J; Uchino J
    Gan To Kagaku Ryoho; 1994 Oct; 21(14):2509-12. PubMed ID: 7944500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of disseminated breast cancer successfully treated with medroxyprogesterone acetate].
    Tsumura I; Okamura Y; Takatsuka Y; Kobayakawa K; Kawahara T
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1509-12. PubMed ID: 2143889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A clinical report of high-dose epirubicin combined with cyclophosphamide and fluorouracil for advanced breast cancer].
    Feng J; Zheng X; Dai A
    Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):468-70. PubMed ID: 10920949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The feasibility of CEF (cyclophosphamide, epirubicin, 5-FU) regimen in the adjuvant setting of primary breast cancer].
    Honda S; Toi M; Shimizu S; Hayashi K; Tominaga T
    Gan To Kagaku Ryoho; 1997 Apr; 24(6):679-83. PubMed ID: 9126304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of liver metastasis of gastric cancer with portal vein tumor thrombosis responding to chemotherapy with 5-FU and epirubicin].
    Yoshida Y; Egami I; Onda M
    Gan To Kagaku Ryoho; 1995 Aug; 22(9):1245-8. PubMed ID: 7661575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of long-term survival of liver metastasis of breast cancer successfully treated with chemotherapy and endocrine therapy].
    Shiba E; Koyama H; Sasaki Y; Iwanaga T; Terasawa T; Wada A
    Gan No Rinsho; 1985 Sep; 31(11):1439-44. PubMed ID: 3934423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of hepatic arterial infusion chemotherapy for multiple liver metastasis from breast cancer].
    Hara S; Hashizume S; Itoyanagi N; Ayabe H; Tagawa Y; Tsuji H; Oka T; Yamamoto S; Shinguu H; Tou K; Tooyama H; Yamazumi K
    Gan To Kagaku Ryoho; 1997 Sep; 24(12):1809-12. PubMed ID: 9382538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival of a patient with primarily chemo-resistant metastatic breast cancer treated with medroxyprogesterone acetate.
    Zaucha R; Sosińska-Mielcarek K; Jassem J
    Breast; 2004 Aug; 13(4):321-4. PubMed ID: 15325667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of gastric cancer with liver metastasis responding to low-dose CDDP/5-FU combination chemotherapy].
    Iwatani Y; Ohno M; Kamigaki T; Nakamura T; Suzuki Y; Iwasaki T; Sinmaru H; Hirata K; Kuroda Y
    Gan To Kagaku Ryoho; 2000 Feb; 27(2):277-80. PubMed ID: 10700900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of breast cancer with multiple metastases successfully treated by medroxyprogesterone acetate with intermittent intra-arterial infusion low-dose chemotherapy to hepatic metastasis].
    Kusama M; Kaise H; Nakayama S; Oota D; Shimizu H; Aoki T; Koyanagi Y
    Gan To Kagaku Ryoho; 2000 Dec; 27(14):2243-7. PubMed ID: 11142170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of bone and lung metastasis of breast cancer successfully treated with radiotherapy, chemotherapy and endocrine therapy].
    Kanda K; Waki S; Uchimura M; Kida H; Narita K; Harada N
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2421-4. PubMed ID: 2260877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of advanced breast cancer leading to DIC after chemotherapy].
    Ishizuka S; Morikawa T; Yoshida K; Nobuhisa T; Endo Y; Watanabe T; Matsumoto Y; Doi Y; Yamada T; Kai K; Nakashima A; Nagahiro I; Sato S; Nakashima A; Nabeyama A
    Gan To Kagaku Ryoho; 2007 Nov; 34(11):1845-8. PubMed ID: 18030021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Usefulness of ambulatory adjuvant chemotherapy with low-dose epirubicin in patients with axially-node positive breast cancer: Chiba Epirubicin Cooperative Study Group].
    Miyauchi M; Yamamoto N; Nakajima N; Suzuki M; Takahashi M; Ohno K; Ogawa K; Tsukamoto T; Yamamoto K; Oheda Y;
    Gan To Kagaku Ryoho; 2001 Jan; 28(1):43-8. PubMed ID: 11201379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A patient with hepatic metastasis of breast cancer successfully treated with combined chemoendocrine therapy using epirubicin, tegafur and tamoxifen].
    Rai Y; Emi Y; Nishijima N; Kai S; Kano T
    Gan To Kagaku Ryoho; 1999 Sep; 26(10):1475-8. PubMed ID: 10500537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of AFP (alpha-fetoprotein) producing gastric cancer successfully treated with FEP (5-FU, Epirubicin, cisplatin) therapy by continuous venous daily infusion of 5-FU and low-dose CDDP].
    Hoshino K; Kawaguchi H; Unate H; Nitta K; Fukui H; Ikeda M; Tsujitani S
    Gan To Kagaku Ryoho; 1996 Aug; 23(9):1197-200. PubMed ID: 8751810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case report of advanced breast cancer with remarkable response to chemoendocrine therapy (CTF + MPA)].
    Yokota T; Fujii T; Roppongi T; Kanno K; Ogata T
    Gan To Kagaku Ryoho; 1998 Apr; 25(5):739-42. PubMed ID: 9571973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting].
    Inaji H; Sakai K; Oka T; Ozawa K; Saito Y; Senoo T; Taguchi T; Terasawa T; Nakao K; Mori T; Koyama H; Oshima A
    Gan To Kagaku Ryoho; 2006 Oct; 33(10):1423-9. PubMed ID: 17033231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease-free survival advantage of weekly epirubicin plus tamoxifen versus tamoxifen alone as adjuvant treatment of operable, node-positive, elderly breast cancer patients: 6-year follow-up results of the French adjuvant study group 08 trial.
    Fargeot P; Bonneterre J; Roché H; Lortholary A; Campone M; Van Praagh I; Monnier A; Namer M; Schraub S; Barats JC; Guastalla JP; Goudier MJ; Chapelle-Marcillac I
    J Clin Oncol; 2004 Dec; 22(23):4622-30. PubMed ID: 15505276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advanced breast cancer with multiple bone metastases successfully treated with combined chemoendocrine-therapy of CEF (cyclophosphamide, epirubicin, 5-fluorouracil) and 5'-DFUR (5'-deoxy-5-fluorouridine) + MPA (medroxyprogesterone acetate)--a case report].
    Fukuda Y; Hirao S; Koyama I; Takatori H; Terakura M; Mayumi K; Tsukazaki Y; Kinoshita H
    Gan To Kagaku Ryoho; 2001 Feb; 28(2):217-20. PubMed ID: 11242649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of advanced male breast cancer successfully treated by 5-fluorouracil, epirubicin and cyclophosphamide chemotherapy combined with tamoxifen.
    Tanaka Y; Ohmori Y; Toki T; Okazaki Y; Ogoshi S; Ogawa Y
    Nihon Geka Hokan; 1995 Jan; 64(1):15-22. PubMed ID: 8534185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.